PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"30320606","Punishment and reinforcement by opioid receptor agonists in a choice procedure in rats","Minervini V, Osteicoechea DC, Casalez A, France CP.","Behav Pharmacol. 2019 Jun;30(4):335-342. doi: 10.1097/FBP.0000000000000436.","Minervini V","Behav Pharmacol","2019","2018/10/16","PMC6461530","NIHMS1504544","10.1097/FBP.0000000000000436"
"29785554","Interactions between kappa and mu opioid receptor agonists: effects of the ratio of drugs in mixtures","Minervini V, Lu HY, Padarti J, Osteicoechea DC, France CP.","Psychopharmacology (Berl). 2018 Aug;235(8):2245-2256. doi: 10.1007/s00213-018-4920-x. Epub 2018 May 22.","Minervini V","Psychopharmacology (Berl)","2018","2018/05/23","PMC6045970","NIHMS969725","10.1007/s00213-018-4920-x"
"27903642","Behavioral Characterization of κ Opioid Receptor Agonist Spiradoline and Cannabinoid Receptor Agonist CP55940 Mixtures in Rats","Minervini V, Dahal S, France CP.","J Pharmacol Exp Ther. 2017 Feb;360(2):280-287. doi: 10.1124/jpet.116.235630. Epub 2016 Nov 30.","Minervini V","J Pharmacol Exp Ther","2017","2016/12/02","PMC5267513","","10.1124/jpet.116.235630"
"26292184","Additive antinociceptive effects of mixtures of the κ-opioid receptor agonist spiradoline and the cannabinoid receptor agonist CP55940 in rats","Maguire DR, France CP.","Behav Pharmacol. 2016 Feb;27(1):69-72. doi: 10.1097/FBP.0000000000000184.","Maguire DR","Behav Pharmacol","2016","2015/08/21","PMC4684971","NIHMS712324","10.1097/FBP.0000000000000184"
"24920732","Effects of peripheral and spinal κ-opioid receptor stimulation on the exercise pressor reflex in decerebrate rats","Copp SW, Stone AJ, Yamauchi K, Kaufman MP.","Am J Physiol Regul Integr Comp Physiol. 2014 Aug 1;307(3):R281-9. doi: 10.1152/ajpregu.00156.2014. Epub 2014 Jun 11.","Copp SW","Am J Physiol Regul Integr Comp Physiol","2014","2014/06/13","PMC4121628","","10.1152/ajpregu.00156.2014"
"24796820","Brief prenatal ethanol exposure alters behavioral sensitivity to the kappa opioid receptor agonist (U62,066E) and antagonist (Nor-BNI) and reduces kappa opioid receptor expression","Nizhnikov ME, Pautassi RM, Carter JM, Landin JD, Varlinskaya EI, Bordner KA, Werner DF, Spear NE.","Alcohol Clin Exp Res. 2014 Jun;38(6):1630-8. doi: 10.1111/acer.12416. Epub 2014 May 5.","Nizhnikov ME","Alcohol Clin Exp Res","2014","2014/05/07","","","10.1111/acer.12416"
"24776303","New evidence of ethanol's anxiolytic properties in the infant rat","Miranda-Morales RS, Nizhnikov ME, Waters DH, Spear NE.","Alcohol. 2014 Jun;48(4):367-74. doi: 10.1016/j.alcohol.2014.01.007. Epub 2014 Apr 8.","Miranda-Morales RS","Alcohol","2014","2014/04/30","PMC4035812","NIHMS584415","10.1016/j.alcohol.2014.01.007"
"24128363","Fischer rats are more sensitive than Lewis rats to the suppressive effects of morphine and the aversive kappa-opioid agonist spiradoline","Freet CS, Wheeler RA, Leuenberger E, Mosblech NA, Grigson PS.","Behav Neurosci. 2013 Oct;127(5):763-70. doi: 10.1037/a0033943.","Freet CS","Behav Neurosci","2013","2013/10/17","PMC3973147","NIHMS564064","10.1037/a0033943"
"23775530","Age-dependent effects of stress on ethanol-induced motor activity in rats","Acevedo MB, Pautassi RM, Spear NE, Spear LP.","Psychopharmacology (Berl). 2013 Dec;230(3):389-98. doi: 10.1007/s00213-013-3163-0. Epub 2013 Jun 18.","Acevedo MB","Psychopharmacology (Berl)","2013","2013/06/19","PMC3859917","NIHMS495106","10.1007/s00213-013-3163-0"
"23604334","Pharmacological activation of kappa opioid receptors: aversive effects in adolescent and adult male rats","Anderson RI, Morales M, Spear LP, Varlinskaya EI.","Psychopharmacology (Berl). 2014 Apr;231(8):1687-93. doi: 10.1007/s00213-013-3095-8. Epub 2013 Apr 19.","Anderson RI","Psychopharmacology (Berl)","2014","2013/04/23","PMC3760984","NIHMS470572","10.1007/s00213-013-3095-8"
"23276674","Stress, κ manipulations, and aversive effects of ethanol in adolescent and adult male rats","Anderson RI, Agoglia AE, Morales M, Varlinskaya EI, Spear LP.","Neuroscience. 2013 Sep 26;249:214-22. doi: 10.1016/j.neuroscience.2012.12.028. Epub 2012 Dec 29.","Anderson RI","Neuroscience","2013","2013/01/02","PMC3670973","NIHMS441404","10.1016/j.neuroscience.2012.12.028"
"22261437","Early role of the κ opioid receptor in ethanol-induced reinforcement","Pautassi RM, Nizhnikov ME, Acevedo MB, Spear NE.","Physiol Behav. 2012 Mar 20;105(5):1231-41. doi: 10.1016/j.physbeh.2012.01.003. Epub 2012 Jan 11.","Pautassi RM","Physiol Behav","2012","2012/01/21","PMC3289852","NIHMS349647","10.1016/j.physbeh.2012.01.003"
"21821697","Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptors","Grimwood S, Lu Y, Schmidt AW, Vanase-Frawley MA, Sawant-Basak A, Miller E, McLean S, Freeman J, Wong S, McLaughlin JP, Verhoest PR.","J Pharmacol Exp Ther. 2011 Nov;339(2):555-66. doi: 10.1124/jpet.111.185108. Epub 2011 Aug 5.","Grimwood S","J Pharmacol Exp Ther","2011","2011/08/09","","","10.1124/jpet.111.185108"
"21666232","Kappa opioid receptor localization and coupling to nitric oxide production in cells of the anterior chamber","Russell-Randall KR, Dortch-Carnes J.","Invest Ophthalmol Vis Sci. 2011 Jul 13;52(8):5233-9. doi: 10.1167/iovs.10-6613.","Russell-Randall KR","Invest Ophthalmol Vis Sci","2011","2011/06/14","PMC3176081","","10.1167/iovs.10-6613"
"21654897","Characterization of intraocular pressure responses of the Tibetan monkey (Macaca thibetana)","Liu G, Zeng T, Yu W, Yan N, Wang H, Cai SP, Pang IH, Liu X.","Mol Vis. 2011;17:1405-13. Epub 2011 May 27.","Liu G","Mol Vis","2011","2011/06/10","PMC3108893","",""
"21420495","Ketanserin potentiates morphine-induced antinociception mediated by kappa-receptor activation","Peiró AM, Climent L, Zapater P, Horga A, Horga JF.","Pharmacol Res. 2011 Jul;64(1):80-4. doi: 10.1016/j.phrs.2011.02.009. Epub 2011 Mar 21.","Peiró AM","Pharmacol Res","2011","2011/03/23","","","10.1016/j.phrs.2011.02.009"
"19859697","Attenuation of cocaine-induced reinstatement of drug seeking in squirrel monkeys: kappa opioid and serotonergic mechanisms","Rüedi-Bettschen D, Rowlett JK, Spealman RD, Platt DM.","Psychopharmacology (Berl). 2010 Jun;210(2):169-77. doi: 10.1007/s00213-009-1705-2. Epub 2009 Oct 27.","Rüedi-Bettschen D","Psychopharmacology (Berl)","2010","2009/10/28","PMC2866039","NIHMS151436","10.1007/s00213-009-1705-2"
"19747933","Effect of kappa-opioid receptor agonists U69593, U50488H, spiradoline and salvinorin A on cocaine-induced drug-seeking in rats","Morani AS, Kivell B, Prisinzano TE, Schenk S.","Pharmacol Biochem Behav. 2009 Dec;94(2):244-9. doi: 10.1016/j.pbb.2009.09.002. Epub 2009 Sep 10.","Morani AS","Pharmacol Biochem Behav","2009","2009/09/15","PMC3021564","NIHMS262851","10.1016/j.pbb.2009.09.002"
"19422370","Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents","Braida D, Capurro V, Zani A, Rubino T, Viganò D, Parolaro D, Sala M.","Br J Pharmacol. 2009 Jul;157(5):844-53. doi: 10.1111/j.1476-5381.2009.00230.x. Epub 2009 May 5.","Braida D","Br J Pharmacol","2009","2009/05/09","PMC2721268","","10.1111/j.1476-5381.2009.00230.x"
"19353808","Antinociceptive interactions of micro- and kappa-opioid agonists in the colorectal distension assay in rats","Briggs SL, Rech RH.","Pharmacol Biochem Behav. 2009 Apr;92(2):343-50. doi: 10.1016/j.pbb.2008.12.023.","Briggs SL","Pharmacol Biochem Behav","2009","2009/04/09","","","10.1016/j.pbb.2008.12.023"
"18598850","Acute delta- and kappa-opioid agonist pretreatment potentiates opioid antagonist-induced suppression of water consumption","White DA, Ballard ME, Harmon AC, Holtzman SG.","Brain Res Bull. 2008 Aug 15;76(6):597-604. doi: 10.1016/j.brainresbull.2008.04.002. Epub 2008 May 9.","White DA","Brain Res Bull","2008","2008/07/05","PMC2504860","NIHMS59434","10.1016/j.brainresbull.2008.04.002"
"18203949","Early postnatal stress alters place conditioning to both mu- and kappa-opioid agonists","Michaels CC, Holtzman SG.","J Pharmacol Exp Ther. 2008 Apr;325(1):313-8. doi: 10.1124/jpet.107.129908. Epub 2008 Jan 18.","Michaels CC","J Pharmacol Exp Ther","2008","2008/01/22","","","10.1124/jpet.107.129908"
"17965283","Expression of a Gi-coupled receptor in the heart causes impaired Ca2+ handling, myofilament injury, and dilated cardiomyopathy","McCloskey DT, Turcato S, Wang GY, Turnbull L, Zhu BQ, Bambino T, Nguyen AP, Lovett DH, Nissenson RA, Karliner JS, Baker AJ.","Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H205-12. doi: 10.1152/ajpheart.00829.2007. Epub 2007 Oct 26.","McCloskey DT","Am J Physiol Heart Circ Physiol","2008","2007/10/30","PMC3372085","NIHMS380617","10.1152/ajpheart.00829.2007"
"17702903","Kappa agonist-induced reinstatement of cocaine seeking in squirrel monkeys: a role for opioid and stress-related mechanisms","Valdez GR, Platt DM, Rowlett JK, Rüedi-Bettschen D, Spealman RD.","J Pharmacol Exp Ther. 2007 Nov;323(2):525-33. doi: 10.1124/jpet.107.125484. Epub 2007 Aug 16.","Valdez GR","J Pharmacol Exp Ther","2007","2007/08/19","","","10.1124/jpet.107.125484"
"17173891","Nociceptin/orphanin FQ blocks the antinociception induced by mu, kappa and delta opioid agonists on the cold water tail-flick test","Chen X, Geller EB, Adler MW.","Eur J Pharmacol. 2007 Feb 14;557(1):32-6. doi: 10.1016/j.ejphar.2006.11.001. Epub 2006 Nov 10.","Chen X","Eur J Pharmacol","2007","2006/12/19","PMC1859853","NIHMS17544","10.1016/j.ejphar.2006.11.001"
"17023055","Neurokinin 1 receptor signaling mediates sex differences in mu and kappa opioid-induced enhancement of contact hypersensitivity","Elliott JC, Wagner AF, Lysle DT.","J Neuroimmunol. 2006 Dec;181(1-2):100-5. doi: 10.1016/j.jneuroim.2006.08.011. Epub 2006 Oct 4.","Elliott JC","J Neuroimmunol","2006","2006/10/07","","","10.1016/j.jneuroim.2006.08.011"
"16397747","Dissociation between sex differences in the immunological, behavioral, and physiological effects of kappa- and delta-opioids in Fischer rats","Elliott JC, Picker MJ, Sparrow AJ, Lysle DT.","Psychopharmacology (Berl). 2006 Mar;185(1):66-75. doi: 10.1007/s00213-005-0267-1. Epub 2006 Jan 6.","Elliott JC","Psychopharmacology (Berl)","2006","2006/01/07","","","10.1007/s00213-005-0267-1"
"16286819","Effects of the long-lasting kappa opioid 2-(3,4-dichlorophenyl)-N-methyl-N-[(1S)-1-(3-isothiocyanatophenyl)-2-(1-pyrrolidinyl) ethyl] acetamide in a drug discrimination and warm water tail-withdrawal procedure","Terner JM, Lomas LM, Lewis JW, Husbands SM, Picker MJ.","Behav Pharmacol. 2005 Dec;16(8):665-70. doi: 10.1097/00008877-200512000-00010.","Terner JM","Behav Pharmacol","2005","2005/11/16","","","10.1097/00008877-200512000-00010"
"15707483","Engineered G protein coupled receptors reveal independent regulation of internalization, desensitization and acute signaling","Scearce-Levie K, Lieberman MD, Elliott HH, Conklin BR.","BMC Biol. 2005 Feb 11;3:3. doi: 10.1186/1741-7007-3-3.","Scearce-Levie K","BMC Biol","2005","2005/02/15","PMC551613","","10.1186/1741-7007-3-3"
"15489045","Action of kappa and Delta opioid agonists on premotor cardiac vagal neurons in the nucleus ambiguus","Wang X, Dergacheva O, Griffioen KJ, Huang ZG, Evans C, Gold A, Bouairi E, Mendelowitz D.","Neuroscience. 2004;129(1):235-41. doi: 10.1016/j.neuroscience.2004.07.021.","Wang X","Neuroscience","2004","2004/10/19","","","10.1016/j.neuroscience.2004.07.021"
"15212988","Placenta ingestion by rats enhances delta- and kappa-opioid antinociception, but suppresses mu-opioid antinociception","DiPirro JM, Kristal MB.","Brain Res. 2004 Jul 16;1014(1-2):22-33. doi: 10.1016/j.brainres.2004.04.006.","DiPirro JM","Brain Res","2004","2004/06/24","","","10.1016/j.brainres.2004.04.006"
"14724041","Sensitivity to the effects of a kappa opioid in rats with free access to exercise wheels: differential effects across behavioral measures","Smith MA, McClean JM, Bryant PA.","Pharmacol Biochem Behav. 2004 Jan;77(1):49-57. doi: 10.1016/j.pbb.2003.09.021.","Smith MA","Pharmacol Biochem Behav","2004","2004/01/16","","","10.1016/j.pbb.2003.09.021"
"14665981","Enhanced sensitivity to the antinociceptive effects of kappa opioids in naltrexone-treated rats: dose- and time-dependent effects","Smith MA, McClean JM, Greene JL.","Behav Pharmacol. 2003 Dec;14(8):641-7. doi: 10.1097/00008877-200312000-00008.","Smith MA","Behav Pharmacol","2003","2003/12/11","","","10.1097/00008877-200312000-00008"
"12847558","A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist","Wadenberg ML.","CNS Drug Rev. 2003 Summer;9(2):187-98. doi: 10.1111/j.1527-3458.2003.tb00248.x.","Wadenberg ML","CNS Drug Rev","2003","2003/07/09","PMC6741666","","10.1111/j.1527-3458.2003.tb00248.x"
"12669175","Interactions between opioids and cocaine on locomotor activity in rats: influence of an opioid's relative efficacy at the mu receptor","Smith MA, Gordon KA, Craig CK, Bryant PA, Ferguson ME, French AM, Gray JD, McClean JM, Tetirick JC.","Psychopharmacology (Berl). 2003 May;167(3):265-73. doi: 10.1007/s00213-003-1388-z. Epub 2003 Apr 1.","Smith MA","Psychopharmacology (Berl)","2003","2003/04/02","","","10.1007/s00213-003-1388-z"
"12576884","Sex differences in (-)-pentazocine antinociception: comparison to morphine and spiradoline in four rat strains using a thermal nociceptive assay","Terner JM, Barrett AC, Cook CD, Picker MJ.","Behav Pharmacol. 2003 Feb;14(1):77-85. doi: 10.1097/00008877-200302000-00008.","Terner JM","Behav Pharmacol","2003","2003/02/11","","","10.1097/00008877-200302000-00008"
"12122483","Age-related differences in sensitivity to the antinociceptive effects of kappa opioids in adult male rats","Smith MA, French AM.","Psychopharmacology (Berl). 2002 Jul;162(3):255-64. doi: 10.1007/s00213-002-1102-6. Epub 2002 Jun 12.","Smith MA","Psychopharmacology (Berl)","2002","2002/07/18","","","10.1007/s00213-002-1102-6"
"12030807","Elevation of atrial natriuretic peptide levels in aqueous humor of the rabbit by kappa opioid receptor agonists","Russell KR, Moore TT, Potter DE.","Neuropeptides. 2001 Oct-Dec;35(5-6):232-7. doi: 10.1054/npep.2001.0883.","Russell KR","Neuropeptides","2001","2002/05/29","","","10.1054/npep.2001.0883"
"11875635","Sex and rat strain determine sensitivity to kappa opioid-induced antinociception","Barrett AC, Cook CD, Terner JM, Roach EL, Syvanthong C, Picker MJ.","Psychopharmacology (Berl). 2002 Mar;160(2):170-81. doi: 10.1007/s00213-001-0949-2. Epub 2001 Dec 20.","Barrett AC","Psychopharmacology (Berl)","2002","2002/03/05","","","10.1007/s00213-001-0949-2"
"11716815","Chronic sucrose intake augments antinociception induced by injections of mu but not kappa opioid receptor agonists into the periaqueductal gray matter in male and female rats","Kanarek RB, Mandillo S, Wiatr C.","Brain Res. 2001 Nov 30;920(1-2):97-105. doi: 10.1016/s0006-8993(01)03039-6.","Kanarek RB","Brain Res","2001","2001/11/22","","","10.1016/s0006-8993(01)03039-6"
"11530849","Prevention of isolation-induced hypertension by intrahippocampal administration of a nonpeptide kappa-opioid receptor agonist","Wright RC, Ingenito AJ.","Hippocampus. 2001;11(4):445-51. doi: 10.1002/hipo.1059.","Wright RC","Hippocampus","2001","2001/09/04","","","10.1002/hipo.1059"
"11483291","Spiradoline, a kappa opioid receptor agonist, produces tonic- and use-dependent block of sodium channels expressed in Xenopus oocytes","Pugsley MK, Yu EJ, Goldin AL.","Gen Pharmacol. 2000 Jun;34(6):417-27. doi: 10.1016/s0306-3623(01)00079-9.","Pugsley MK","Gen Pharmacol","2000","2001/08/03","","","10.1016/s0306-3623(01)00079-9"
"11479004","Engineering receptors activated solely by synthetic ligands (RASSLs)","Scearce-Levie K, Coward P, Redfern CH, Conklin BR.","Trends Pharmacol Sci. 2001 Aug;22(8):414-20. doi: 10.1016/s0165-6147(00)01743-0.","Scearce-Levie K","Trends Pharmacol Sci","2001","2001/08/02","","","10.1016/s0165-6147(00)01743-0"
"11446767","Kappa opioid agonist-induced changes in IOP: correlation with 3H-NE release and cAMP accumulation","Moore TT, Potter DE.","Exp Eye Res. 2001 Aug;73(2):167-78. doi: 10.1006/exer.2001.1022.","Moore TT","Exp Eye Res","2001","2001/07/12","","","10.1006/exer.2001.1022"
"11275411","Effects of a kappa agonist, spiradoline mesylate (U62,066E), on activation and vaginocervical-stimulation produced analgesia in rats","Boyle TJ, Masuda T, Cunningham ST.","Brain Res Bull. 2001 Jan 15;54(2):213-8. doi: 10.1016/s0361-9230(00)00453-6.","Boyle TJ","Brain Res Bull","2001","2001/03/29","","","10.1016/s0361-9230(00)00453-6"
"11162293","Hippocampal administration of kappa-opioid receptor antisense exacerbates isolation-induced hypertension","Wright RC, Ingenito AJ.","Neuropeptides. 2000 Dec;34(6):360-7. doi: 10.1054/npep.2000.0839.","Wright RC","Neuropeptides","2000","2001/02/13","","","10.1054/npep.2000.0839"
"10899364","Further characterization of the discriminative stimulus effects of spiradoline","Holtzman SG.","Pharmacol Biochem Behav. 2000 Jul;66(3):517-22. doi: 10.1016/s0091-3057(00)00172-6.","Holtzman SG","Pharmacol Biochem Behav","2000","2000/07/19","","","10.1016/s0091-3057(00)00172-6"
"10758129","Differential effects of mu-, delta-, and kappa-opioid receptor agonists on mechanosensitive gastric vagal afferent fibers in the rat","Ozaki N, Sengupta JN, Gebhart GF.","J Neurophysiol. 2000 Apr;83(4):2209-16. doi: 10.1152/jn.2000.83.4.2209.","Ozaki N","J Neurophysiol","2000","2000/04/12","","","10.1152/jn.2000.83.4.2209"
"10669508","Effects of intracolonic opioid receptor agonists on polymodal pelvic nerve afferent fibers in the rat","Su X, Julia V, Gebhart GF.","J Neurophysiol. 2000 Feb;83(2):963-70. doi: 10.1152/jn.2000.83.2.963.","Su X","J Neurophysiol","2000","2000/02/11","","","10.1152/jn.2000.83.2.963"
"10663428","Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids","Zhang L, Walker EA, Sutherland J 2nd, Young AM.","Psychopharmacology (Berl). 2000 Feb;148(2):136-45. doi: 10.1007/s002130050035.","Zhang L","Psychopharmacology (Berl)","2000","2000/02/09","","","10.1007/s002130050035"
"10647770","Synergistic centrally mediated cardiovascular effects of a kappa opioid agonist and an alpha2-adrenoceptor agonist","Shen S, Ingenito AJ.","Gen Pharmacol. 1999 Dec;33(6):449-56. doi: 10.1016/s0306-3623(99)00041-5.","Shen S","Gen Pharmacol","1999","2000/01/27","","","10.1016/s0306-3623(99)00041-5"
"10638642","Intake of a palatable sucrose solution modifies the actions of spiradoline, a kappa opioid receptor agonist, on analgesia and feeding behavior in male and female rats","Kanarek RB, Homoleski BA, Wiatr C.","Pharmacol Biochem Behav. 2000 Jan 1;65(1):97-104. doi: 10.1016/s0091-3057(99)00181-1.","Kanarek RB","Pharmacol Biochem Behav","2000","2000/01/19","","","10.1016/s0091-3057(99)00181-1"
"10591871","Effects of E-2078, a stable dynorphin A(1-8) analog, on sedation and serum prolactin levels in rhesus monkeys","Butelman ER, Harris TJ, Kreek MJ.","Psychopharmacology (Berl). 1999 Nov;147(1):73-80. doi: 10.1007/s002130051144.","Butelman ER","Psychopharmacology (Berl)","1999","1999/12/11","","","10.1007/s002130051144"
"10499161","Participation of central and peripheral kappa 1 and kappa 2 opioid receptors in arrhythmogenesis","Lishmanov YB, Maslov LN, Ugdyzhekova DS.","Clin Exp Pharmacol Physiol. 1999 Sep;26(9):716-23. doi: 10.1046/j.1440-1681.1999.03115.x.","Lishmanov YB","Clin Exp Pharmacol Physiol","1999","1999/09/28","","","10.1046/j.1440-1681.1999.03115.x"
"10448921","Differential antagonism of the rate-decreasing effects of kappa-opioid receptor agonists by naltrexone and norbinaltorphimine","Powell KR, Holtzman SG.","Eur J Pharmacol. 1999 Jul 14;377(1):21-8. doi: 10.1016/s0014-2999(99)00394-5.","Powell KR","Eur J Pharmacol","1999","1999/08/17","","","10.1016/s0014-2999(99)00394-5"
"10423608","Sustained antihypertensive effects of chronic administration of two kappa-opioid agonists in spontaneously hypertensive rats","Zhai QZ, Ingenito AJ.","Am J Ther. 1997 May-Jun;4(5-6):173-80. doi: 10.1097/00045391-199705000-00003.","Zhai QZ","Am J Ther","1997","1997/05/01","","","10.1097/00045391-199705000-00003"
"10404951","Comparison of cardiovascular responses to intra-hippocampal mu, delta and kappa opioid agonists in spontaneously hypertensive rats and isolation-induced hypertensive rats","Shen S, Ingenito AJ.","J Hypertens. 1999 Apr;17(4):497-505. doi: 10.1097/00004872-199917040-00007.","Shen S","J Hypertens","1999","1999/07/15","","","10.1097/00004872-199917040-00007"
"10403501","Ligands for opioid and sigma-receptors improve cardiac electrical stability in rat models of post-infarction cardiosclerosis and stress","Lishmanov YuB, Maslov LN, Naryzhnaya NV, Tam SW.","Life Sci. 1999;65(1):PL13-7. doi: 10.1016/s0024-3205(99)00226-x.","Lishmanov YuB","Life Sci","1999","1999/07/14","","","10.1016/s0024-3205(99)00226-x"
"10225482","Depressor effect of kappa opioid agonist on hypertension induced by isolation in the rat","Shen S, Ingenito AJ.","Clin Exp Hypertens. 1999 Apr;21(3):275-97. doi: 10.3109/10641969909068667.","Shen S","Clin Exp Hypertens","1999","1999/05/04","","","10.3109/10641969909068667"
"10052353","Conditional expression and signaling of a specifically designed Gi-coupled receptor in transgenic mice","Redfern CH, Coward P, Degtyarev MY, Lee EK, Kwa AT, Hennighausen L, Bujard H, Fishman GI, Conklin BR.","Nat Biotechnol. 1999 Feb;17(2):165-9. doi: 10.1038/6165.","Redfern CH","Nat Biotechnol","1999","1999/03/03","","","10.1038/6165"
"9869491","Sodium channel-blocking properties of spiradoline, a kappa receptor agonist, are responsible for its antiarrhythmic action in the rat","Pugsley MK, Saint DA, Hayes ES, Kramer D, Walker MJ.","J Cardiovasc Pharmacol. 1998 Dec;32(6):863-74. doi: 10.1097/00005344-199812000-00002.","Pugsley MK","J Cardiovasc Pharmacol","1998","1998/12/30","","","10.1097/00005344-199812000-00002"
"9825134","[The use of opiate receptor ligands for correction of heart electrical instability]","Lishmanov IuB, Krylatov AV, Naryzhnaia NV, Maslov LN.","Biull Eksp Biol Med. 1998 Oct;126(10):399-401.","Lishmanov IuB","Biull Eksp Biol Med","1998","1998/11/24","","",""
"9729284","Gender differences in kappa-opioid modulation of cocaine-induced behavior and NMDA-evoked dopamine release","Sershen H, Hashim A, Lajtha A.","Brain Res. 1998 Aug 10;801(1-2):67-71. doi: 10.1016/s0006-8993(98)00546-0.","Sershen H","Brain Res","1998","1998/09/05","","","10.1016/s0006-8993(98)00546-0"
"9641463","Comparative hypotensive actions of three nonpeptide kappa opioid agonists on hippocampus of SHRs and normotensive WKY rats","Zhai QZ, Ingenito AJ.","J Cardiovasc Pharmacol. 1998 Jun;31(6):806-12. doi: 10.1097/00005344-199806000-00002.","Zhai QZ","J Cardiovasc Pharmacol","1998","1998/06/26","","","10.1097/00005344-199806000-00002"
"9632230","Kappa antinociceptive activity of spiradoline in the cold-water tail-flick assay in rats","Briggs SL, Rech RH, Sawyer DC.","Pharmacol Biochem Behav. 1998 Jun;60(2):467-72. doi: 10.1016/s0091-3057(98)00017-3.","Briggs SL","Pharmacol Biochem Behav","1998","1998/06/19","","","10.1016/s0091-3057(98)00017-3"
"9302101","Coupling of the cloned rat kappa-opioid receptor to adenylyl cyclase is dependent on receptor expression","Hirst RA, Hirota K, Grandy DK, Lambert DG.","Neurosci Lett. 1997 Aug 29;232(2):119-22. doi: 10.1016/s0304-3940(97)00594-6.","Hirst RA","Neurosci Lett","1997","1997/08/29","","","10.1016/s0304-3940(97)00594-6"
"9185329","Comparison of the effects of a series of kappa-opioid receptor agonists upon sodium channel function in rat brain miniprisms","Tiger G, Fowler CJ.","Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1997 May;117(1):69-73. doi: 10.1016/s0742-8413(96)00233-2.","Tiger G","Comp Biochem Physiol C Pharmacol Toxicol Endocrinol","1997","1997/05/01","","","10.1016/s0742-8413(96)00233-2"
"9138682","The effects of spiradoline (U-62066E), a kappa-opioid receptor agonist, on neuroendocrine function in man","Ur E, Wright DM, Bouloux PM, Grossman A.","Br J Pharmacol. 1997 Mar;120(5):781-4. doi: 10.1038/sj.bjp.0700971.","Ur E","Br J Pharmacol","1997","1997/03/01","PMC1564535","","10.1038/sj.bjp.0700971"
"9092881","Dopaminergic and glutamatergic mechanisms mediate the induction of FOS-like protein by cocaethylene","Horowitz JM, DiPirro JM, Kristal MB, Torres G.","Brain Res Bull. 1997;42(5):393-8. doi: 10.1016/s0361-9230(96)00327-9.","Horowitz JM","Brain Res Bull","1997","1997/01/01","","","10.1016/s0361-9230(96)00327-9"
"8915966","Water transport in cultured cells from the rat inner medullary collecting duct","Hubbard JI.","J Am Soc Nephrol. 1996 Oct;7(10):2062-71.","Hubbard JI","J Am Soc Nephrol","1996","1996/10/01","","",""
"8844699","Prolonged antagonism of morphine-induced locomotor stimulation by kappa opioid agonists: enhancement by prior morphine exposure","Pearl SM, Glick SD.","Neurosci Lett. 1996 Jul 26;213(1):5-8. doi: 10.1016/0304-3940(96)12822-6.","Pearl SM","Neurosci Lett","1996","1996/07/26","","","10.1016/0304-3940(96)12822-6"
"8836521","Kappa opioid receptor agonists inhibit sigma-1 (sigma 1) receptor binding in guinea-pig brain, liver and spleen: autoradiographical evidence","Brent PJ.","Brain Res. 1996 Jul 1;725(2):155-65. doi: 10.1016/0006-8993(96)00170-9.","Brent PJ","Brain Res","1996","1996/07/01","","","10.1016/0006-8993(96)00170-9"
"8741947","Effects of kappa receptor agonists on D1 and D2 dopamine agonist and antagonist-induced behaviors","Marin C, Engber TM, Chaudhuri P, Peppe A, Chase TN.","Psychopharmacology (Berl). 1996 Jan;123(2):215-21. doi: 10.1007/BF02246181.","Marin C","Psychopharmacology (Berl)","1996","1996/01/01","","","10.1007/BF02246181"
"8429499","New degradation product of spiradoline mesylate in aqueous solution: formation of an imidazolidine ring","Ogata M, Shimizu R, Abe H.","J Pharm Sci. 1993 Jan;82(1):91-4. doi: 10.1002/jps.2600820120.","Ogata M","J Pharm Sci","1993","1993/01/01","","","10.1002/jps.2600820120"
"8411771","Effects of spiradoline mesylate, a selective kappa-opioid-receptor agonist, on the central dopamine system with relation to mouse locomotor activity and analgesia","Kunihara M, Ohyama M, Nakano M.","Jpn J Pharmacol. 1993 Jul;62(3):223-30. doi: 10.1254/jjp.62.223.","Kunihara M","Jpn J Pharmacol","1993","1993/07/01","","","10.1254/jjp.62.223"
"8396784","Neuroendocrine and behavioral effects of the selective kappa agonist spiradoline in Tourette's syndrome: a pilot study","Chappell PB, Leckman JF, Scahill LD, Hardin MT, Anderson G, Cohen DJ.","Psychiatry Res. 1993 Jun;47(3):267-80. doi: 10.1016/0165-1781(93)90084-t.","Chappell PB","Psychiatry Res","1993","1993/06/01","","","10.1016/0165-1781(93)90084-t"
"8208776","Monoamine systems in the discriminative effects of spiradoline, a kappa-opioid agonist","Holtzman SG, Steinfels GF.","Pharmacol Biochem Behav. 1994 Mar;47(3):575-8. doi: 10.1016/0091-3057(94)90161-9.","Holtzman SG","Pharmacol Biochem Behav","1994","1994/03/01","","","10.1016/0091-3057(94)90161-9"
"8208766","Assessing spiradoline-like discriminative effects of DuP 747: influence of route of administration","Holtzman SG, Steinfels GF, Schmidt WK.","Pharmacol Biochem Behav. 1994 Mar;47(3):487-91. doi: 10.1016/0091-3057(94)90148-1.","Holtzman SG","Pharmacol Biochem Behav","1994","1994/03/01","","","10.1016/0091-3057(94)90148-1"
"8106151","Dynorphin agonist therapy of Parkinson's disease","Giuffra M, Mouradian MM, Davis TL, Ownby J, Chase TN.","Clin Neuropharmacol. 1993 Oct;16(5):444-7. doi: 10.1097/00002826-199310000-00007.","Giuffra M","Clin Neuropharmacol","1993","1993/10/01","","","10.1097/00002826-199310000-00007"
"8070500","The cardiovascular and central nervous system effects in the human of U-62066E. A selective opioid receptor agonist","Rimoy GH, Wright DM, Bhaskar NK, Rubin PC.","Eur J Clin Pharmacol. 1994;46(3):203-7. doi: 10.1007/BF00192549.","Rimoy GH","Eur J Clin Pharmacol","1994","1994/01/01","","","10.1007/BF00192549"
"7996463","Antinociceptive and response rate-altering effects of kappa opioid agonists, spiradoline, enadoline and U69,593, alone and in combination with opioid antagonists in squirrel monkeys","Pitts RC, Dykstra LA.","J Pharmacol Exp Ther. 1994 Dec;271(3):1501-8.","Pitts RC","J Pharmacol Exp Ther","1994","1994/12/01","","",""
"7981769","The influence of the kappa agonist-spiradoline (U62066E) on the analgesic activity of some opioids at the spinal level","Stachura Z, Herman ZS.","Pol J Pharmacol. 1994 Jan-Apr;46(1-2):37-41.","Stachura Z","Pol J Pharmacol","1994","1994/01/01","","",""
"7932577","Selective kappa-opioid agonists: synthesis and structure-activity relationships of piperidines incorporating on oxo-containing acyl group","Giardina G, Clarke GD, Dondio G, Petrone G, Sbacchi M, Vecchietti V.","J Med Chem. 1994 Oct 14;37(21):3482-91. doi: 10.1021/jm00047a006.","Giardina G","J Med Chem","1994","1994/10/14","","","10.1021/jm00047a006"
"7895075","Intracerebroventricular treatment with an antisense oligodeoxynucleotide to kappa-opioid receptors inhibited kappa-agonist-induced analgesia in rats","Adams JU, Chen X, DeRiel JK, Adler MW, Liu-Chen LY.","Brain Res. 1994 Dec 19;667(1):129-32. doi: 10.1016/0006-8993(94)91723-x.","Adams JU","Brain Res","1994","1994/12/19","","","10.1016/0006-8993(94)91723-x"
"7892412","Antagonism of the discriminative stimulus effects of the kappa-opioid agonist spiradoline","Holtzman SG, Steinfels GF.","Psychopharmacology (Berl). 1994 Nov;116(3):243-8. doi: 10.1007/BF02245324.","Holtzman SG","Psychopharmacology (Berl)","1994","1994/11/01","","","10.1007/BF02245324"
"7851477","Comparative effects of selective kappa-opioid receptor agonists on dopamine levels in the dorsal caudate of freely moving rats","Zaratin P, Clarke GD.","Eur J Pharmacol. 1994 Oct 24;264(2):151-6. doi: 10.1016/0014-2999(94)00451-x.","Zaratin P","Eur J Pharmacol","1994","1994/10/24","","","10.1016/0014-2999(94)00451-x"
"7774656","An antisense oligodeoxynucleotide to mu-opioid receptors inhibits mu-opioid receptor agonist-induced analgesia in rats","Chen XH, Adams JU, Geller EB, DeRiel JK, Adler MW, Liu-Chen LY.","Eur J Pharmacol. 1995 Feb 24;275(1):105-8. doi: 10.1016/0014-2999(95)00012-a.","Chen XH","Eur J Pharmacol","1995","1995/02/24","","","10.1016/0014-2999(95)00012-a"
"7757494","The effect of ibogaine on kappa-opioid- and 5-HT3-induced changes in stimulation-evoked dopamine release in vitro from striatum of C57BL/6By mice","Sershen H, Hashim A, Lajtha A.","Brain Res Bull. 1995;36(6):587-91. doi: 10.1016/0361-9230(94)00250-5.","Sershen H","Brain Res Bull","1995","1995/01/01","","","10.1016/0361-9230(94)00250-5"
"7745131","Dynorphin opioid inhibition of cocaine-induced, D1 dopamine receptor-mediated immediate-early gene expression in the striatum","Steiner H, Gerfen CR.","J Comp Neurol. 1995 Mar 6;353(2):200-12. doi: 10.1002/cne.903530204.","Steiner H","J Comp Neurol","1995","1995/03/06","","","10.1002/cne.903530204"
"7562503","The role of serotonin in the effects of opioids in squirrel monkeys responding under a titration procedure: I. Kappa opioids","Powell KR, Dykstra LA.","J Pharmacol Exp Ther. 1995 Sep;274(3):1305-16.","Powell KR","J Pharmacol Exp Ther","1995","1995/09/01","","",""
"7556401","kappa-Opioid receptor agonist protects against ischemic reduction of 2-deoxyglucose uptake in morphine-tolerant rats","Shibata S, Tominaga K, Watanabe S.","Eur J Pharmacol. 1995 Jun 12;279(2-3):197-202. doi: 10.1016/0014-2999(95)00152-b.","Shibata S","Eur J Pharmacol","1995","1995/06/12","","","10.1016/0014-2999(95)00152-b"
"7552272","Kappa opioid inhibition of morphine and cocaine self-administration in rats","Glick SD, Maisonneuve IM, Raucci J, Archer S.","Brain Res. 1995 May 29;681(1-2):147-52. doi: 10.1016/0006-8993(95)00306-b.","Glick SD","Brain Res","1995","1995/05/29","","","10.1016/0006-8993(95)00306-b"
"3414991","Enhancement of anesthetic effect of halothane by spiradoline, a selective kappa-agonist","Althaus JS, DiFazio CA, Moscicki JC, VonVoigtlander PF.","Anesth Analg. 1988 Sep;67(9):823-7.","Althaus JS","Anesth Analg","1988","1988/09/01","","",""
"3027300","Diuretic actions in man of a selective kappa opioid agonist: U-62,066E","Peters GR, Ward NJ, Antal EG, Lai PY, deMaar EW.","J Pharmacol Exp Ther. 1987 Jan;240(1):128-31.","Peters GR","J Pharmacol Exp Ther","1987","1987/01/01","","",""
"2850873","Cardiovascular depressant effects of the kappa opioid receptor agonists U50488H and spiradoline mesylate","Hall ED, Wolf DL, McCall RB.","Circ Shock. 1988 Dec;26(4):409-17.","Hall ED","Circ Shock","1988","1988/12/01","","",""
"2840759","Quantitative analysis of effects of kappa-opioid agonists on postischemic hippocampal CA1 neuronal necrosis in gerbils","Hall ED, Pazara KE.","Stroke. 1988 Aug;19(8):1008-12. doi: 10.1161/01.str.19.8.1008.","Hall ED","Stroke","1988","1988/08/01","","","10.1161/01.str.19.8.1008"
"2839665","Analgesic and mechanistic evaluation of spiradoline, a potent kappa opioid","Vonvoigtlander PF, Lewis RA.","J Pharmacol Exp Ther. 1988 Jul;246(1):259-62.","Vonvoigtlander PF","J Pharmacol Exp Ther","1988","1988/07/01","","",""
"2796604","Analgesic activity of spiradoline mesylate (U-62,066E), a kappa opioid agonist in mice","Kunihara M, Ohyama M, Nakano M, Hayashi S.","Life Sci. 1989;45(13):1191-8. doi: 10.1016/0024-3205(89)90508-0.","Kunihara M","Life Sci","1989","1989/01/01","","","10.1016/0024-3205(89)90508-0"
"2560430","An in vitro profile of activity for the (+) and (-) enantiomers of spiradoline and PD117302","Meecham KG, Boyle SJ, Hunter JC, Hughes J.","Eur J Pharmacol. 1989 Dec 7;173(2-3):151-7. doi: 10.1016/0014-2999(89)90512-8.","Meecham KG","Eur J Pharmacol","1989","1989/12/07","","","10.1016/0014-2999(89)90512-8"
"2552077","Spinal analgesic actions of kappa receptor agonists, U-50488H and spiradoline (U-62066)","Piercey MF, Einspahr FJ.","J Pharmacol Exp Ther. 1989 Oct;251(1):267-71.","Piercey MF","J Pharmacol Exp Ther","1989","1989/10/01","","",""
"2547626","Mechanism of diuretic action of U-62,066E, a kappa opioid receptor agonist","Yamada K, Imai M, Yoshida S.","Eur J Pharmacol. 1989 Jan 31;160(2):229-37. doi: 10.1016/0014-2999(89)90495-0.","Yamada K","Eur J Pharmacol","1989","1989/01/31","","","10.1016/0014-2999(89)90495-0"
"2272363","Antitussive effects of two specific kappa-opioid agonists, U-50,488H and U-62,066E, in rats","Kamei J, Tanihara H, Kasuya Y.","Eur J Pharmacol. 1990 Oct 9;187(2):281-6. doi: 10.1016/0014-2999(90)90014-w.","Kamei J","Eur J Pharmacol","1990","1990/10/09","","","10.1016/0014-2999(90)90014-w"
"2158377","Inhibition of elevated arginine vasopressin secretion in response to osmotic stimulation and acute haemorrhage by U-62066E, a kappa-opioid receptor agonist","Yamada K, Nakano M, Yoshida S.","Br J Pharmacol. 1990 Feb;99(2):384-8. doi: 10.1111/j.1476-5381.1990.tb14713.x.","Yamada K","Br J Pharmacol","1990","1990/02/01","PMC1917399","","10.1111/j.1476-5381.1990.tb14713.x"
"1966562","Kappa agonists and vasopressin secretion","Hamon G, Jouquey S.","Horm Res. 1990;34(3-4):129-32. doi: 10.1159/000181811.","Hamon G","Horm Res","1990","1990/01/01","","","10.1159/000181811"
"1744997","The abilities of specific kappa-opioid agonists, U-50,488H and U-62,066E, to cause antitussive tolerance were lower than that of morphine","Kamei J, Tanihara H, Kasuya Y.","Jpn J Pharmacol. 1991 Aug;56(4):557-61. doi: 10.1254/jjp.56.557.","Kamei J","Jpn J Pharmacol","1991","1991/08/01","","","10.1254/jjp.56.557"
"1716056","Atrial natriuretic polypeptide secretion via selective activation of kappa-opioid receptor: role of dynorphin","Yamada K, Yoshida S, Shimada Y.","Am J Physiol. 1991 Sep;261(3 Pt 1):E293-7. doi: 10.1152/ajpendo.1991.261.3.E293.","Yamada K","Am J Physiol","1991","1991/09/01","","","10.1152/ajpendo.1991.261.3.E293"
"1663252","Discriminative stimulus effects of spiradoline, a kappa-opioid agonist","Holtzman SG, Cook L, Steinfels GF.","Psychopharmacology (Berl). 1991;105(4):447-52. doi: 10.1007/BF02244362.","Holtzman SG","Psychopharmacology (Berl)","1991","1991/01/01","","","10.1007/BF02244362"
"1663039","The kappa-opioid receptor agonist spiradoline differentially alters the rotational response to dopamine D1 and D2 agonists","Engber TM, Boldry RC, Chase TN.","Eur J Pharmacol. 1991 Jul 23;200(1):171-3. doi: 10.1016/0014-2999(91)90682-g.","Engber TM","Eur J Pharmacol","1991","1991/07/23","","","10.1016/0014-2999(91)90682-g"
"1660789","Inhibitory effect of spiradoline, a kappa opioid receptor agonist, on Ca2+ induced contraction and the intracellular Ca2+ concentration in porcine coronary artery","Harasawa Y, Kimura M, Hayashi S.","Cardiovasc Res. 1991 Oct;25(10):802-6. doi: 10.1093/cvr/25.10.802.","Harasawa Y","Cardiovasc Res","1991","1991/10/01","","","10.1093/cvr/25.10.802"
"1659438","Mechanism of diuretic action of spiradoline (U-62066E)--a kappa opioid receptor agonist in the human","Rimoy GH, Bhaskar NK, Wright DM, Rubin PC.","Br J Clin Pharmacol. 1991 Nov;32(5):611-5. doi: 10.1111/j.1365-2125.1991.tb03960.x.","Rimoy GH","Br J Clin Pharmacol","1991","1991/11/01","PMC1368639","","10.1111/j.1365-2125.1991.tb03960.x"
"1353613","Kappa opioid agonists inhibit transmitter release from guinea pig hippocampal mossy fiber synaptosomes","Gannon RL, Terrian DM.","Neurochem Res. 1992 Aug;17(8):741-7. doi: 10.1007/BF00969007.","Gannon RL","Neurochem Res","1992","1992/08/01","","","10.1007/BF00969007"
"1346721","Analgesic and discriminative stimulus properties of U-62,066E, the selective kappa-opioid receptor agonist, in the rat","Ohno M, Yamamoto T, Ueki S.","Psychopharmacology (Berl). 1992;106(1):31-8. doi: 10.1007/BF02253585.","Ohno M","Psychopharmacology (Berl)","1992","1992/01/01","","","10.1007/BF02253585"
"1327807","Long term kappa-opioid receptor blockade following nor-binaltorphimine","Jones DN, Holtzman SG.","Eur J Pharmacol. 1992 May 14;215(2-3):345-8. doi: 10.1016/0014-2999(92)90055-9.","Jones DN","Eur J Pharmacol","1992","1992/05/14","","","10.1016/0014-2999(92)90055-9"
"1325350","Central monoaminergic mechanisms in mice and analgesic activity of spiradoline mesylate, a selective kappa-opioid receptor agonist","Kunihara M, Ohyama M, Nakano M.","Eur J Pharmacol. 1992 Apr 22;214(2-3):111-8. doi: 10.1016/0014-2999(92)90107-f.","Kunihara M","Eur J Pharmacol","1992","1992/04/22","","","10.1016/0014-2999(92)90107-f"
"1321982","Modulation of kappa-mediated antitussive activity in rats by a delta-agonist","Kamei J, Tanihara H, Kasuya Y.","Res Commun Chem Pathol Pharmacol. 1992 Jun;76(3):375-8.","Kamei J","Res Commun Chem Pathol Pharmacol","1992","1992/06/01","","",""
"1319495","Selective reversible and irreversible ligands for the kappa opioid receptor","Cheng CY, Wu SC, Hsin LW, Tam SW.","J Med Chem. 1992 Jun 12;35(12):2243-7. doi: 10.1021/jm00090a015.","Cheng CY","J Med Chem","1992","1992/06/12","","","10.1021/jm00090a015"
"1317055","Pre- and post-synaptic effects of spiradoline and U-50488H, selective kappa opioid receptor agonists, in isolated ileum","Nomura Y, Hayashi S.","Scand J Gastroenterol. 1992 Apr;27(4):295-302. doi: 10.3109/00365529209000078.","Nomura Y","Scand J Gastroenterol","1992","1992/04/01","","","10.3109/00365529209000078"
"1282270","Kappa agonist-induced reduction in dopamine release: site of action and tolerance","Donzanti BA, Althaus JS, Payson MM, Von Voigtlander PF.","Res Commun Chem Pathol Pharmacol. 1992 Nov;78(2):193-210.","Donzanti BA","Res Commun Chem Pathol Pharmacol","1992","1992/11/01","","",""
